Lifecore Biomedical (LFCR) Announces Cooperation Agreement with 22NW, Legion Partners and Wynnefield Partners

Key Summary: On May 16, 2024, 22NW Fund (12.5%) nominated six individuals for the Board of Directors. The company's 2023 AGM is on August 15, 2024. The company informed 22NW Fund that only Class II Directors will be elected. Thus, only Class II nominees will be up for election. 22NW Fund can reassign the nominees' classes for the election. On July 1, 20…